Global Radiopharmaceuticals Market 2023-2027

Description

List of Tables

The radiopharmaceuticals market is forecasted to grow by USD 4612.62 mn during 2022-2027, accelerating at a CAGR of 10.22% during the forecast period. The report on the radiopharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by a rising incidence of neurological disorders, growing cancer cases rising investment in the oncology market, and minimal side effects of radiopharmaceuticals.

Technavio's radiopharmaceuticals market is segmented as below:

Market Scope
Base Year	2022
End Year	2027
Series Year	2023-2027
Growth Momentum	Accelerate
YOY 2023	10.02%
CAGR	10.22%
Incremental Value	$4612.62mn

By Source

Cyclotrons
Nuclear reactors

By End-user

Diagnostics
Therapeutics

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the production of cyclotron-based radiopharmaceuticals as one of the prime reasons driving the radiopharmaceuticals market growth during the next few years. Also, discovery and development of new radiopharmaceuticals and improvement in healthcare infrastructure in emerging economies will lead to sizable demand in the market.

The report on the radiopharmaceuticals market covers the following areas:

Radiopharmaceuticals market sizing
Radiopharmaceuticals market forecast
Radiopharmaceuticals market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading radiopharmaceuticals market vendors that include Bayer AG, Bracco Spa, Cardinal Health Inc., Curium Pharma, Eckert and Ziegler AG, General Electric Co., IBA Radiopharma Solutions, Jubilant Pharma Ltd., Lantheus Holdings Inc., Mallinckrodt Plc, NorthStar Medical Radioisotopes LLC, Novartis AG, NTP Radioisotopes SOC Ltd., PharmaLogic Holdings Corp., Positron Corp., Radiomedix Inc., Siemens AG, Sinotau Pharmaceuticals, Telix Pharmaceuticals Ltd., and Sotera Health Co.. Also, the radiopharmaceuticals market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR43963

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Source
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global radiopharmaceuticals market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global radiopharmaceuticals market 2017 - 2021 ($ million)
4.2 Source Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Source Segment 2017 - 2021 ($ million)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Source

6.1 Market segments
Exhibit 30: Chart on Source - Market share 2022-2027 (%)
Exhibit 31: Data Table on Source - Market share 2022-2027 (%)
6.2 Comparison by Source
Exhibit 32: Chart on Comparison by Source
Exhibit 33: Data Table on Comparison by Source
6.3 Cyclotrons - Market size and forecast 2022-2027
Exhibit 34: Chart on Cyclotrons - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Cyclotrons - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Cyclotrons - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Cyclotrons - Year-over-year growth 2022-2027 (%)
6.4 Nuclear reactors - Market size and forecast 2022-2027
Exhibit 38: Chart on Nuclear reactors - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Nuclear reactors - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Nuclear reactors - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Nuclear reactors - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Source
Exhibit 42: Market opportunity by Source ($ million)
Exhibit 43: Data Table on Market opportunity by Source ($ million)

7 Market Segmentation by End-user

7.1 Market segments
Exhibit 44: Chart on End-user - Market share 2022-2027 (%)
Exhibit 45: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 46: Chart on Comparison by End-user
Exhibit 47: Data Table on Comparison by End-user
7.3 Diagnostics - Market size and forecast 2022-2027
Exhibit 48: Chart on Diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Diagnostics - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Diagnostics - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Diagnostics - Year-over-year growth 2022-2027 (%)
7.4 Therapeutics - Market size and forecast 2022-2027
Exhibit 52: Chart on Therapeutics - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Therapeutics - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Therapeutics - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Therapeutics - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by End-user
Exhibit 56: Market opportunity by End-user ($ million)
Exhibit 57: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 87: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 91: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 Bayer AG
Exhibit 107: Bayer AG - Overview
Exhibit 108: Bayer AG - Business segments
Exhibit 109: Bayer AG - Key news
Exhibit 110: Bayer AG - Key offerings
Exhibit 111: Bayer AG - Segment focus
12.4 Bracco Spa
Exhibit 112: Bracco Spa - Overview
Exhibit 113: Bracco Spa - Product / Service
Exhibit 114: Bracco Spa - Key offerings
12.5 Cardinal Health Inc.
Exhibit 115: Cardinal Health Inc. - Overview
Exhibit 116: Cardinal Health Inc. - Business segments
Exhibit 117: Cardinal Health Inc. - Key news
Exhibit 118: Cardinal Health Inc. - Key offerings
Exhibit 119: Cardinal Health Inc. - Segment focus
12.6 Curium Pharma
Exhibit 120: Curium Pharma - Overview
Exhibit 121: Curium Pharma - Product / Service
Exhibit 122: Curium Pharma - Key offerings
12.7 Eckert and Ziegler AG
Exhibit 123: Eckert and Ziegler AG - Overview
Exhibit 124: Eckert and Ziegler AG - Business segments
Exhibit 125: Eckert and Ziegler AG - Key news
Exhibit 126: Eckert and Ziegler AG - Key offerings
Exhibit 127: Eckert and Ziegler AG - Segment focus
12.8 General Electric Co.
Exhibit 128: General Electric Co. - Overview
Exhibit 129: General Electric Co. - Business segments
Exhibit 130: General Electric Co. - Key news
Exhibit 131: General Electric Co. - Key offerings
Exhibit 132: General Electric Co. - Segment focus
12.9 IBA Radiopharma Solutions
Exhibit 133: IBA Radiopharma Solutions - Overview
Exhibit 134: IBA Radiopharma Solutions - Business segments
Exhibit 135: IBA Radiopharma Solutions - Key offerings
Exhibit 136: IBA Radiopharma Solutions - Segment focus
12.10 Jubilant Pharma Ltd.
Exhibit 137: Jubilant Pharma Ltd. - Overview
Exhibit 138: Jubilant Pharma Ltd. - Product / Service
Exhibit 139: Jubilant Pharma Ltd. - Key offerings
12.11 Lantheus Holdings Inc.
Exhibit 140: Lantheus Holdings Inc. - Overview
Exhibit 141: Lantheus Holdings Inc. - Business segments
Exhibit 142: Lantheus Holdings Inc. - Key offerings
Exhibit 143: Lantheus Holdings Inc. - Segment focus
12.12 NorthStar Medical Radioisotopes LLC
Exhibit 144: NorthStar Medical Radioisotopes LLC - Overview
Exhibit 145: NorthStar Medical Radioisotopes LLC - Product / Service
Exhibit 146: NorthStar Medical Radioisotopes LLC - Key offerings
12.13 Novartis AG
Exhibit 147: Novartis AG - Overview
Exhibit 148: Novartis AG - Business segments
Exhibit 149: Novartis AG - Key offerings
Exhibit 150: Novartis AG - Segment focus
12.14 NTP Radioisotopes SOC Ltd.
Exhibit 151: NTP Radioisotopes SOC Ltd. - Overview
Exhibit 152: NTP Radioisotopes SOC Ltd. - Product / Service
Exhibit 153: NTP Radioisotopes SOC Ltd. - Key offerings
12.15 PharmaLogic Holdings Corp.
Exhibit 154: PharmaLogic Holdings Corp. - Overview
Exhibit 155: PharmaLogic Holdings Corp. - Product / Service
Exhibit 156: PharmaLogic Holdings Corp. - Key offerings
12.16 Siemens AG
Exhibit 157: Siemens AG - Overview
Exhibit 158: Siemens AG - Business segments
Exhibit 159: Siemens AG - Key news
Exhibit 160: Siemens AG - Key offerings
Exhibit 161: Siemens AG - Segment focus
12.17 Sotera Health Co.
Exhibit 162: Sotera Health Co. - Overview
Exhibit 163: Sotera Health Co. - Business segments
Exhibit 164: Sotera Health Co. - Key offerings
Exhibit 165: Sotera Health Co. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 166: Inclusions checklist
Exhibit 167: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 168: Currency conversion rates for US$
13.4 Research methodology
Exhibit 169: Research methodology
Exhibit 170: Validation techniques employed for market sizing
Exhibit 171: Information sources
13.5 List of abbreviations
Exhibit 172: List of abbreviations